Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Plos One|January 31, 2017
Correction: Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor EffectZiye Pan, Jinjiao He, Lubna M Rasoul, et al.
Plos One|October 14, 2016
Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor EffectZiye Pan, Jinjiao He, Lubna M Rasoul, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2017
The pharmacological efficacy of the anti-IL17 scFv and sTNFR1 bispecific fusion protein in inflammation mouse stimulated by LPSYongbi Yang, Teng Zhang, Hongxue Cao, et al.
Journal of Pharmacological Sciences|May 14, 2016
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapyYunzhou Wu, Jinjiao He, Ying An, et al.
Technology in Cancer Research & Treatment|March 21, 2014
Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma ModelZeshan Niu, Fuliang Bai, Tian Sun, et al.
Cancer Gene Therapy|November 3, 2025
Development and preclinical evaluation of ovNDV-28: a chimeric Newcastle disease virus expressing human IL-2 for cancer therapyTianyan Liu, Zhihang Liu, Dan Yu, et al.
Journal of Biomedical Science|July 29, 2016
Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma modelYing An, Tianyan Liu, Jinjiao He, et al.
International Immunopharmacology|May 8, 2014
Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse modelQingcui Li, Guiping Ren, Liming Xu, et al.
Journal of Medical Virology|August 12, 2020
The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice modelJinjiao He, Ying An, Jianying Qi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2018
Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in miceZhihang Liu, Han Liu, Pengfei Xu, et al.
Pageof 10